Example: Heart Attack

Search clinical trials for: Pancreatic Polypeptide

Total 24 results

NCT03854708

Completed

Effect of Pancreatic Polypeptide on Gastric Motor Function and Food Intake in Humans

Conditions: Hunger
NCT00791076

Terminated

The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients

Conditions: Diabetes Mellitus, Type 1
NCT03396146

Recruiting

Assay for the Pancreatic Polypeptide: an Help for Clinical Practice Guidelines in Classification of the Diabetes

Conditions: Type1diabetes
NCT02221765

Terminated

Safety, Tolerability and Efficacy Study of PP1420 in HV

Conditions: Obesity
NCT03338387

Enrolling by invitation

Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

Conditions: Eating Disorder; Bulimia Nervosa
NCT04514588

Recruiting

Associations Between Genetic Markers of Caffeine Metabolism, Appetite Hormones and Body Weight

Conditions: Food Consumption and Appetite; Food Habits; Caffeine
NCT01052493

Completed

A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects

Conditions: Obesity
NCT00652405

Completed

Effect of Alcohol on Cephalic Phase Reflex and Gene Expression

Conditions: Type 2 Diabetes; Inflammation; Carbohydrate&Lipid Metabolism; Oral Processing
NCT01951729

Completed

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Conditions: Pre-diabetes
NCT00416767

Completed

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Conditions: Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
NCT00602082

Completed

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Conditions: Gastrointestinal Carcinoid Tumor; Islet Cell Tumor
NCT00730483

Terminated

Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors

Conditions: Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Metastatic Cancer
NCT00538850

Completed

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Conditions: Cancer
NCT00466856

Terminated

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Conditions: Head and Neck Cancer; Islet Cell Tumor; Metastatic Cancer; Pheochromocytoma
NCT00454376

Unknown status

Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors

Conditions: Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Metastatic Cancer; Neoplastic Syndrome
NCT00427349

Completed

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Conditions: Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
NCT00227773

Withdrawn

Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

Conditions: Gastrointestinal Carcinoid Tumor; Islet Cell Carcinoma
NCT00227617

Terminated

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Conditions: Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Tumor
NCT00096083

Completed

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Conditions: Cancer
NCT00005842

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Conditions: Cancer
NCT00005860

Completed

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Conditions: Cancer
NCT00006368

Completed

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Conditions: Brain and Central Nervous System Tumors; Breast Cancer; Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Lymphoma; Melanoma (Skin); Neoplastic Syndrome
NCT00002947

Terminated

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Conditions: Brain and Central Nervous System Tumors; Childhood Langerhans Cell Histiocytosis; Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Intraocular Melanoma; Islet Cell Tumor; Kidney Cancer; Lung Cancer; Melanoma (Skin); Neoplastic Syndrome; Neuroendocrine Carcinoma of the Skin; Pheochromocytoma
NCT00027638

Completed

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

Conditions: Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome